Literature DB >> 1451747

D-cycloserine reverses the working memory impairment of hippocampal-lesioned rats in a spatial learning task.

G M Schuster1, W J Schmidt.   

Abstract

It is shown that D-cycloserine has cognition-enhancing properties in quinolinic acid hippocampal-lesioned rats. Lesioned rats had a severe impairment of working memory in an allocentric spatial reversal paradigm in the 8-arm maze, and performance could be restored with 12 mg/kg i.p. D-cycloserine, given 30 min before testing. The present findings favour the testing of D-cycloserine for clinical efficacy in patients with Alzheimer's disease with loss of pyramidal neurons and disconnected glycine-NMDA receptor activation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1451747     DOI: 10.1016/0014-2999(92)94825-g

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  20 in total

Review 1.  Pharmacological treatments that facilitate extinction of fear: relevance to psychotherapy.

Authors:  Michael Davis; Karyn M Myers; Jasmeer Chhatwal; Kerry J Ressler
Journal:  NeuroRx       Date:  2006-01

2.  NMDA receptor and schizophrenia: a brief history.

Authors:  Joseph T Coyle
Journal:  Schizophr Bull       Date:  2012-09       Impact factor: 9.306

Review 3.  Could Dietary Glutamate Play a Role in Psychiatric Distress?

Authors:  A Zarina Kraal; Nicole R Arvanitis; Andrew P Jaeger; Vicki L Ellingrod
Journal:  Neuropsychobiology       Date:  2019-01-30       Impact factor: 2.328

4.  Identification of AICP as a GluN2C-Selective N-Methyl-d-Aspartate Receptor Superagonist at the GluN1 Glycine Site.

Authors:  Maja Jessen; Kristen Frederiksen; Feng Yi; Rasmus P Clausen; Kasper B Hansen; Hans Bräuner-Osborne; Paul Kilburn; Anders Damholt
Journal:  Mol Pharmacol       Date:  2017-06-06       Impact factor: 4.436

5.  Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats.

Authors:  W Löscher; P Wlaź; C Rundfeldt; H Baran; D Hönack
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

6.  Inhibition of serine palmitoyltransferase reduces Aβ and tau hyperphosphorylation in a murine model: a safe therapeutic strategy for Alzheimer's disease.

Authors:  Hirosha Geekiyanage; Aditi Upadhye; Christina Chan
Journal:  Neurobiol Aging       Date:  2013-03-23       Impact factor: 4.673

Review 7.  The role of the N-methyl-D-aspartate receptor in Alzheimer's disease: therapeutic potential.

Authors:  P Murali Doraiswamy
Journal:  Curr Neurol Neurosci Rep       Date:  2003-09       Impact factor: 5.081

8.  D-cycloserine enhances short-delay, but not long-delay, conditioned taste aversion learning in rats.

Authors:  Rachel A Davenport; Thomas A Houpt
Journal:  Pharmacol Biochem Behav       Date:  2008-10-07       Impact factor: 3.533

Review 9.  Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site.

Authors:  Seong S Shim; Michael D Hammonds; Baik S Kee
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-09-27       Impact factor: 5.270

Review 10.  The Role of Serine Racemase in the Pathophysiology of Brain Disorders.

Authors:  Joseph T Coyle; Darrick T Balu
Journal:  Adv Pharmacol       Date:  2017-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.